BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37174070)

  • 1. Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer.
    Lombaers MS; Cornel KMC; Visser NCM; Bulten J; Küsters-Vandevelde HVN; Amant F; Boll D; Bronsert P; Colas E; Geomini PMAJ; Gil-Moreno A; van Hamont D; Huvila J; Krakstad C; Kraayenbrink AA; Koskas M; Mancebo G; Matías-Guiu X; Ngo H; Pijlman BM; Vos MC; Weinberger V; Snijders MPLM; van Koeverden SW; Enitec-Consortium ; Haldorsen IS; Reijnen C; Pijnenborg JMA
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer.
    Lei H; Xu S; Mao X; Chen X; Chen Y; Sun X; Sun P
    J Inflamm Res; 2021; 14():7131-7142. PubMed ID: 34992410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
    Miller HA; Tran A; LyBarger KS; Frieboes HB
    Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and evaluation of a risk-scoring system for lymph node metastasis in early-stage endometrial carcinoma: Achieving preoperative risk stratification.
    Zhang Y; Zhao W; Chen Z; Zhao X; Ren P; Zhu M
    J Obstet Gynaecol Res; 2020 Nov; 46(11):2305-2313. PubMed ID: 32844525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting.
    Shawn LyBarger K; Miller HA; Frieboes HB
    Sci Rep; 2022 Nov; 12(1):19783. PubMed ID: 36396713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer.
    Ünsal M; Kimyon Comert G; Karalok A; Basaran D; Turkmen O; Boyraz G; Tasci T; Koc S; Boran N; Tulunay G; Turan T
    Ginekol Pol; 2018; 89(11):599-606. PubMed ID: 30508211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative markers for the prediction of high-risk features in endometrial cancer.
    Panyavaranant P; Manchana T
    World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer.
    Asami Y; Hiranuma K; Takayanagi D; Matsuda M; Shimada Y; Kato MK; Kuno I; Murakami N; Komatsu M; Hamamoto R; Kohno T; Sekizawa A; Matsumoto K; Kato T; Yoshida H; Shiraishi K
    Sci Rep; 2022 Nov; 12(1):19004. PubMed ID: 36347927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for pelvic lymph node metastasis in endometrial cancer.
    Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
    Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Factors Related to Lymph Node Metastasis in Early-Stage Type 1 Endometrial Cancer: Verifying the Clinical Value of Positive Threshold of the Immunohistochemical Parameter Ki67.
    Jiang P; Yuan R
    Cancer Manag Res; 2021; 13():6319-6328. PubMed ID: 34413681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Serum Calcium Level Promotes the Risk of Lymph Node Metastasis in Endometrial Cancer.
    Li XC; Dong YY; Cheng Y; Zhou JY; Yang X; Shen BQ; Wu XT; Li XP; Wang JL
    Cancer Manag Res; 2020; 12():5023-5030. PubMed ID: 32612389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer.
    Hsiao YY; Fu HC; Wu CH; Lan J; Ou YC; Tsai CC; Lin H
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
    Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.
    Reijnen C; IntHout J; Massuger LFAG; Strobbe F; Küsters-Vandevelde HVN; Haldorsen IS; Snijders MPLM; Pijnenborg JMA
    Oncologist; 2019 Sep; 24(9):e880-e890. PubMed ID: 31186375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial Cancer.
    Prueksaritanond N; Angsathapon S; Insin P
    Gynecol Obstet Invest; 2023; 88(1):53-60. PubMed ID: 36596280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
    Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
    PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer.
    Fasmer KE; Hodneland E; Dybvik JA; Wagner-Larsen K; Trovik J; Salvesen Ø; Krakstad C; Haldorsen IHS
    J Magn Reson Imaging; 2021 Mar; 53(3):928-937. PubMed ID: 33200420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.